170 related articles for article (PubMed ID: 38533382)
1. Alteration in gut microbiota is associated with immune imbalance in Graves' disease.
Liu Y; Tang S; Feng Y; Xue B; Cheng C; Su Y; Wei W; Zhang L; Huang Z; Shi X; Fang Y; Yang J; Zhang Y; Deng X; Wang L; Ren H; Wang C; Yuan H
Front Cell Infect Microbiol; 2024; 14():1349397. PubMed ID: 38533382
[TBL] [Abstract][Full Text] [Related]
2. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid.
Su X; Yin X; Liu Y; Yan X; Zhang S; Wang X; Lin Z; Zhou X; Gao J; Wang Z; Zhang Q
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785703
[TBL] [Abstract][Full Text] [Related]
3. Yanning Syrup ameliorates the lipopolysaccharide-induced inflammation: Adjusting the gut microbiota, short-chain fatty acids, and the CD4
Wei D; Ma P; Fan Q; Yu H; Peng Y; Li X
J Ethnopharmacol; 2022 Jan; 283():114729. PubMed ID: 34634365
[TBL] [Abstract][Full Text] [Related]
4. Gut Microbiota May Play a Significant Role in the Pathogenesis of Graves' Disease.
Jiang W; Yu X; Kosik RO; Song Y; Qiao T; Tong J; Liu S; Fan S; Luo Q; Chai L; Lv Z; Li D
Thyroid; 2021 May; 31(5):810-820. PubMed ID: 33234057
[No Abstract] [Full Text] [Related]
5. The role and molecular mechanism of gut microbiota in Graves' orbitopathy.
Li Y; Luo B; Tong B; Xie Z; Cao J; Bai X; Peng Y; Wu Y; Wang W; Qi X
J Endocrinol Invest; 2023 Feb; 46(2):305-317. PubMed ID: 35986869
[TBL] [Abstract][Full Text] [Related]
6. The Role of the Microbiota in Graves' Disease and Graves' Orbitopathy.
Hou J; Tang Y; Chen Y; Chen D
Front Cell Infect Microbiol; 2021; 11():739707. PubMed ID: 35004341
[TBL] [Abstract][Full Text] [Related]
7. Elevated Levels of Circulating Biomarkers Related to Leaky Gut Syndrome and Bacterial Translocation Are Associated With Graves' Disease.
Zheng D; Liao H; Chen S; Liu X; Mao C; Zhang C; Meng M; Wang Z; Wang Y; Jiang Q; Xue Y; Zhou L; Chen Y
Front Endocrinol (Lausanne); 2021; 12():796212. PubMed ID: 34975767
[TBL] [Abstract][Full Text] [Related]
8. Alterations of Gut Microbiota in Patients With Graves' Disease.
Chang SC; Lin SF; Chen ST; Chang PY; Yeh YM; Lo FS; Lu JJ
Front Cell Infect Microbiol; 2021; 11():663131. PubMed ID: 34026662
[TBL] [Abstract][Full Text] [Related]
9. Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease.
Moshkelgosha S; Verhasselt HL; Masetti G; Covelli D; Biscarini F; Horstmann M; Daser A; Westendorf AM; Jesenek C; Philipp S; Diaz-Cano S; Banga JP; Michael D; Plummer S; Marchesi JR; Eckstein A; Ludgate M; Berchner-Pfannschmidt U;
Microbiome; 2021 Feb; 9(1):45. PubMed ID: 33593429
[TBL] [Abstract][Full Text] [Related]
10. Comparative assessment of gut microbial composition and function in patients with Graves' disease and Graves' orbitopathy.
Shi TT; Xin Z; Hua L; Wang H; Zhao RX; Yang YL; Xie RR; Liu HY; Yang JK
J Endocrinol Invest; 2021 Feb; 44(2):297-310. PubMed ID: 32449092
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease.
Masetti G; Moshkelgosha S; Köhling HL; Covelli D; Banga JP; Berchner-Pfannschmidt U; Horstmann M; Diaz-Cano S; Goertz GE; Plummer S; Eckstein A; Ludgate M; Biscarini F; Marchesi JR;
Microbiome; 2018 May; 6(1):97. PubMed ID: 29801507
[TBL] [Abstract][Full Text] [Related]
12. Human umbilical cord mesenchymal stem cells ameliorate colon inflammation via modulation of gut microbiota-SCFAs-immune axis.
Liu A; Liang X; Wang W; Wang C; Song J; Guo J; Sun D; Wang D; Song M; Qian J; Zhang X
Stem Cell Res Ther; 2023 Sep; 14(1):271. PubMed ID: 37749611
[TBL] [Abstract][Full Text] [Related]
13. Molecular Alteration Analysis of Human Gut Microbial Composition in Graves' disease Patients.
Ishaq HM; Mohammad IS; Shahzad M; Ma C; Raza MA; Wu X; Guo H; Shi P; Xu J
Int J Biol Sci; 2018; 14(11):1558-1570. PubMed ID: 30263008
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis of gut microbiota and its correlation with dysregulation of cytokines in psoriasis patients.
Zhang X; Shi L; Sun T; Guo K; Geng S
BMC Microbiol; 2021 Mar; 21(1):78. PubMed ID: 33685393
[TBL] [Abstract][Full Text] [Related]
15. Associations between gut microbiota and thyroidal function status in Chinese patients with Graves' disease.
Chen J; Wang W; Guo Z; Huang S; Lei H; Zang P; Lu B; Shao J; Gu P
J Endocrinol Invest; 2021 Sep; 44(9):1913-1926. PubMed ID: 33481211
[TBL] [Abstract][Full Text] [Related]
16. Gut dysbiosis is associated with primary hypothyroidism with interaction on gut-thyroid axis.
Su X; Zhao Y; Li Y; Ma S; Wang Z
Clin Sci (Lond); 2020 Jun; 134(12):1521-1535. PubMed ID: 32519746
[TBL] [Abstract][Full Text] [Related]
17. Parthenolide ameliorates colon inflammation through regulating Treg/Th17 balance in a gut microbiota-dependent manner.
Liu YJ; Tang B; Wang FC; Tang L; Lei YY; Luo Y; Huang SJ; Yang M; Wu LY; Wang W; Liu S; Yang SM; Zhao XY
Theranostics; 2020; 10(12):5225-5241. PubMed ID: 32373209
[TBL] [Abstract][Full Text] [Related]
18. The Potential Role of Pyrroloquinoline Quinone to Regulate Thyroid Function and Gut Microbiota Composition of Graves' Disease in Mice.
Liu X; Jiang W; Lu G; Qiao T; Gao D; Zhang M; Cai H; Chai L; Yi W; Lv Z
Pol J Microbiol; 2023 Dec; 72(4):443-460. PubMed ID: 38095308
[TBL] [Abstract][Full Text] [Related]
19. Dysbiosis of Gut Microbiota and Short-Chain Fatty Acids in Encephalitis: A Chinese Pilot Study.
Xu R; Tan C; He Y; Wu Q; Wang H; Yin J
Front Immunol; 2020; 11():1994. PubMed ID: 32973805
[TBL] [Abstract][Full Text] [Related]
20. Alterations in gut microbiome and metabolomics in chronic hepatitis B infection-associated liver disease and their impact on peripheral immune response.
Shen Y; Wu SD; Chen Y; Li XY; Zhu Q; Nakayama K; Zhang WQ; Weng CZ; Zhang J; Wang HK; Wu J; Jiang W
Gut Microbes; 2023; 15(1):2155018. PubMed ID: 36519342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
